Brussels, 11/10/2002 (Agence Europe) - By the end of the year, the Commission should set in place a group of experts entrusted with the task of defining the implications for both research and industry of European patent law on human stem cells and on gene sequences isolated from the human body. This is announced in a report on the evolution and the implications of the patents law in the field of biotechnology and genetic engineering, which gives a first report on the directive on the legal...